Highlights and Quick Summary
- Other current liabilities for the quarter ending December 31, 2022 was $1.7 Million (a -20.98% decrease compared to previous quarter)
- Year-over-year quarterly Other current liabilities increased by 7.48%
- Annual Other current liabilities for 2022 was $400 Thousand (a -54.65% decrease from previous year)
- Annual Other current liabilities for 2021 was $882 Thousand (a 33.23% increase from previous year)
- Annual Other current liabilities for 2020 was $662 Thousand (a 340.75% increase from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Other current liabilities of Benitec Biopharma Limited
Most recent Other current liabilitiesof BNTC including historical data for past 10 years.Interactive Chart of Other current liabilities of Benitec Biopharma Limited
Benitec Biopharma Limited Other current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $1.7 | $2.15 | $0.4 | $1.58 | $0.4 |
| 2021 | $1.59 | $1.08 | $0.88 | $0.6 | $0.88 |
| 2020 | – | $0.22 | $0.52 | $0.51 | $0.66 |
| 2019 | – | – | – | $0.15 | $0.15 |
| 2018 | – | – | – | – | $0.13 |
| 2017 | – | – | – | $0.17 | $0.16 |
| 2016 | – | $0.17 | $0.14 | $0.09 | $0.15 |
| 2015 | – | – | $0.08 | $0.16 | $0.16 |
| 2014 | – | – | $0.15 | $0.15 | $0.15 |
| 2013 | $0.1 | – | – | – | $0.1 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology